Biotage AB and McMaster University Sign Joint Agreement to Develop New Chemistry Platform to Speed the Production of Molecular Imaging and Therapy Agents
STOCKHOLM, Sweden--(BUSINESS WIRE)--As part of the agreement, Biotage (STO:BIOTA) will provide funding and instruments, including an Initiator microwave synthesizer, SP4 flash purification system, and V10 Evaporator. These automated instruments work together to streamline workflow and speed production. The McMaster Institute of Applied Radiation Sciences (McIARS) will apply funding and equipment to speed the development of novel molecular imaging agents for PET and SPECT and radiotherapy agents for treatment applications. Biotage is the only company that offers solutions for synthesis, purification and evaporation, providing instruments and consumables for these key development steps.